U.S. Markets open in 14 hrs, 20 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,450.95 | 132.79 | 1.29% |
| NASDAQ | 2,176.01 | 29.97 | 1.40% |
| S&P 500 | 1,106.24 | 14.86 | 1.36% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 20.37 09:30 AM EST | |
|---|---|---|
| Day High | 20.86 09:57 AM EST |
|
| Range | 0.49 |
| Volume | 190,726 | |
|---|---|---|
| 30-Day Avg Vol | 116,000 |
|
| Difference | 64.42% |
| Market Cap | 394.87 M | |
|---|---|---|
| Mkt Cap Chg | 11.09 M |
| Shares Out | 19.12 M | |
|---|---|---|
| % Shrs Traded | 1.00% | |
| 1yr EPS Est | -1.89 |
| 52-Wk Low | 8.52 | |
|---|---|---|
| 52-Wk High | 25.15 |
|
| Range | 16.63 |
| Prev Close | 20.07 11/20/09 | |
|---|---|---|
| Today's Open | 20.37 | |
| Change | 1.49% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 411,324.00 |
| Revenue (LFY) | 82.85 M | |
|---|---|---|
| Earnings (LFY) | -86.51 M | |
| Earnings (MRQ) | -18.38 M | |
| Next Earn Est | -1.249 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -5.12 | |
| 1yr EPS Growth | 63.30% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -10.00 | |
| PEG Ratio | — | |
| Return on Equity | -184.67 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Affymax is designing peptides to give red blood cells a pep talk. The biotechnology firm is researching and developing possible drugs based upon these biological process regulators. Its leading drug candidate, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -1.249 3/8/10 | — — |
—
—
|
| Last Quarter | -1.229 9/30/09 | -0.97 9/30/09 |
0.259
Beat
|
| 2 Quarters Ago | -1.266 6/30/09 | -1.17 6/30/09 |
0.096
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 29.16 M | 82.85 M |
| Gross Profit | 28.60 M | 81.56 M |
| Operating Income | -18.73 M | -88.73 M |
| Net Income | -18.38 M | -86.51 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts